IQVIA

Views & Analysis

How to Successfully Employ External Comparator Arm Studies U...

Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs).

Views & Analysis

Is the launch environment really more competitive now?

It’s often stated - mostly without reference to data - that the environment for innovative launches is more competitive now than it ever has been. Is this true?

Sales & Marketing

Unlocking the potential of connected commercialisation solut...

It is no secret that today’s post-pandemic healthcare landscape in the UK is very different to its pre-pandemic counterpart.

Views & Analysis

Moving to component management & traceability: progress, bar...

Component management is fairly new to the regulatory market, with pharmaceutical firms moving from traditional document management systems to more dynamic component content management syste

Views & Analysis

Rethinking trial engagement and recruitment starts with pati...

With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pa

Oncology